Effects of adjuvant on neuropeptide-like immunoreactivity in experimentally induced temporomandibular arthritis in rats

Archives of Oral Biology

Volumn 41, Issue 7, 1996, Pages 705-712

  Carleson, J ^a,b   Alstergren, P ^b   Appelgren, A ^b   Appelgren, B ^b   Kopp, S ^b   Srinivasan, G R ^c   Theodorsson, E ^c   Lundeberg, T ^a,d  

^a Division of Physiology II   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Dept of Rehab and Phys Medicine   (Sweden)

Author keywords

arthritis; neuropeptides; temporomandibular joint

Indexed keywords

BACTERIAL PROTEIN; CALCITONIN GENE RELATED PEPTIDE; NEUROKININ; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P;

ADJUVANT ARTHRITIS; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; CONTROLLED STUDY; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOMODULATION; MALE; METABOLISM; MYCOBACTERIUM; NONHUMAN; PHYSIOLOGY; RAT; RAT STRAIN; STATISTICS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; TISSUE DISTRIBUTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BACTERIAL PROTEINS; CALCITONIN GENE-RELATED PEPTIDE; IMMUNOHISTOCHEMISTRY; MALE; MYCOBACTERIUM; NEUROIMMUNOMODULATION; NEUROKININ A; NEUROPEPTIDE Y; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; SUBSTANCE P; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0030186160     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(96)00027-1     Document Type: Article

References (50)

1. Benuck M. and Marks N. (1975) Enzymatic inactivation of Substance P by a partially purified enzyme from rat brain. Biochem. biophys. Res. Commun. 65, 13-160.
2. Bileviciute I., Lundeberg T., Ekblom A. and Theodorsson E. (1993) Bilateral changes of Substance P-, neurokinin A-, calcitonin gene-related peptide and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci. Lett. 153, 37-40.
3. Brain S. D., Williams T. J., Tippins J. R., Morris H. R. MacIntyre I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56.
4. 2-adrenoceptors. Neuroscience 34, 521-523.
5. Donnerer J., Schuligoi R. and Stein C. (1992) Increased content and transport of Substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49, 693-698.
6. Duggan A. W., Hendry I. A., Morton C. R., Hutchiso W. D. and Zhao Z. O. (1988) Cutaneous stimuli releasing immunoreactive Substance P in the dorsal horn of the cat. Brain Res. 451, 261-273.
7. Duggan A. W. and Nedry I. A. (1986) Laminar localization of the sites of release of immunoreactive Substance P in the dorsal horn with antibody-coated microelectrodes. Neurosci. Lett. 68, 134-140.
8. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A. and Cohen I. R. (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natn Acad. Sci. U.S.A. 82, 5117-5120.
9. van Eden W., Thole J. E. R., van der Zee R., Noordzij A., van Embden J. D. A., Hensen E. J. and Cohen I. R. (1988) Cloning of the mycobacterial epitope recognized by T-lymphocytes in adjuvant arthritis. Nature 331, 171-173.
10. Erdös E. G. and Skidgel R. A. (1989) Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormons. FASEB J. 3, 145-151.
11. Freund J. (1951) The effect of paraffin oil and mycobacteria on antibody formation and sensitization. Am. J. Clin. Pathol. 21, 645-656.
12. Fried G., Lundberg J. M. and Theodorsson-Norheim E. (1985) Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol. Scand. 125, 145-154.
13. Gamse R., Mroz E., Leeman S. and Lembeck F. (1978) The intestine as source of immunoreactive Substance P in plasma of the cat. Nau.-Schmied. Arch. Pharmacol. 305, 17-21.
14. Gamse R., Petsche U., Lembeck F. and Jansco G. (1987) Capsaicin applied to peripheral nerve inhibits axoplasmic transport of Substance P and somatostatin. Brain Res. 239, 447-462.
15. Gamse R., Posch M., Saria A. and Jansco G. (1981) Several mediators appear to interact in neurogenic inflammation. Acta Physiol. Hung. 69, 343-354.
16. Gaston J. S. H., Life P. F., Bailey L. C. and Bacon P. A. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J. Immunol. 143, 2494-2500.
17. Gray T. S. and Morley J. E. (1986) Minireview. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38, 389-401.
18. Hökfelt T., Ljungdahl A., Steinbusch H., Verhofstad A., Nilsson G., Brodin E., Pernow B. and Goldstein M. (1978) Immunohistochemical evidence of Substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience 3, 517-538.
19. Hope P. J., Jarrott B., Schaible H. G., Clarke R. W. and Duggan A. W. (1990) Release and spread of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis. Brain Res. 533, 292-299.
20. Hukkanen M., Konttinen Y. T., Terenghi G. and Polak J. M. (1992) Peptide-containing innervation of rat femoral lymphatic vessels. Microvasc. Res. 43, 7-19.
21. Ischida-Yamamoto A. and Tohoyama M. (1989) Calcitonin gene-related peptide in the nervous tissue. Progr. Neurobiol. 33, 335-386.
22. Karlsson-Parra A., Söderström K., Ferm M., Ivanyi J., Kiessling R. and Klareskog L. (1990) Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand. J. Immunol. 31, 283-288.
23. Kimball E. S., Persico F. J. and Vaught J. L. (1988) Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. J. Immunol. 141, 3564-3569.
24. Krukoff T. L. (1987) Neuropeptide Y-like immunoreactivity in cat spinal cord with special reference to autonomic areas. Brain Res. 415, 300-308.
25. Larsson J., Ekblom A.. Henriksson K., Lundeberg T. and Theodorsson E. (1991) Concentration of Substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis . Scand. J. Rheumat. 20(5), 326-335.
26. Levine J. D., Clark R., Devor M., Helms C., Moskowitz M. A. and Basbaum A. I. (1984) Intraneuronal Substance P contributes to the severity of experimental arthritis. Science 226, 547-549.
27. Levine J. D., Dardick S. J., Roizen M. F., Helms C. and Basbaum A. I. (1986) Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci. 6, 3423-3429.
28. Lotz M., Carson D. A. and Vaughan J. H. (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235, 893-895.
29. Lotz M., Vaughan J. H. and Carson D. A. (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241, 1218-1221.
30. Louis S. M., Johnstone D., Millest A. J., Russell N. J. and Dockray G. J. (1990) Immunization with calcitonin gene-related peptide reduces the inflammatory response to adjuvant arthritis in the rat. Neuroscience 39, 727-731.
31. Louis S. M., Russell N. J. W., Jamieson A. and Dockray G. J. (1988) The role of calcitonin gene-related peptide (CGRP) and Substance P(SP) in neurogenic inflammatory responses in the rat. Regul. Pept. 22, 416.
32. Lundberg J. M., Franco-Cereceda A., Alving K., Delay-Goyet P. and Lou Y. P. (1992) Release of calcitonin gene-related peptide from sensory neurons. Ann. NY Acad. Sci. 657, 187-193.
33. Lundberg J. M., Franco-Cereceda A., Hua X., Hökfelt T. Fischer J. A. (1985) Co-existence of Substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur. J. Pharmacol. 108, 315-319.
34. Lundberg J. M., Terenius L., Hökfelt T., Martling C.-R., Tatemoto K., Mutt V., Polak J., Bloom S. and Goldstein M. (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480.
35. McKelvey J. F., Davis B. M., Krause J. E. and Cabot J. B. (1982) Contribution of bulbospinal and intraspinal pathways to Substance P-like immunoreactivity in the thoracic spinal cord. Soc. Neurosci. Abstr. 8, 584.
36. Minami M., Kuraishi Y., Kawamura M., Yamaguchi T., Masu Y., Nakanishi S. and Satoh M. (1989) Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of Substance P-containing spinal neurons in nociception. Neurosci. Lett. 102, 257-260.
37. Morris M., Kapoor V. and Chalmers J. (1987) Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and the adrenal medulla. J. Cardiovasc. Dis. 9, 541-545.
38. Morton C. R. and Hutchison W. D. (1989) Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin. Neuroscience 31, 807-815.
39. Nadel J. A. (1989) Neutral endopeptidase modulates neurogenic inflammation. Eur. Resp. J. 4, 745-754.
40. Partsch G., Matucci-Cerinic M., Marabini S., Jantsch S., Pignone A. and Cagnoni M. (1991) Collagenase synthesis of rheumatoid arthritis synoviocytes: dose-dependent stimulation by Substance P and capsaicin. Scand. J. Rheumatol. 20, 98-103.
41. Risling M., Dalsgaard C. J. and Cuello A. C. (1984) Invasion of lumbosacral ventral roots and spinal pia mater by Substance P-immunoreactive axons after sciatic nerve lesion in kittens. Brain Res. 307, 351-354.
42. Romano T. A., Felten S. Y., Felten D. Y. and Olschowka J. A. (1991) Neuropeptide-Y-innervation of the rat spleen: another potential immunomodulatory neuropeptide . Brain Behav. Immun. 5, 116-131.
43. Rosenfeld M. G., Mermod J. J., Amara S. G., Swanson L. W., Sawchenko P. E., Rivier J., Vale W. W. and Evans R. M. (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304, 129-135.
44. Schaible H. G., Jarrott B., Hope P. J. and Duggan A. W. (1990) Release of immunoreactive Substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res. 529, 214-223.
45. Shanahan F. and Anton P. (1988) Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease. Digest. Dis. Sci. 33 (Suppl.), 41S-49S.
46. Takano Y., Martin J. E., Leeman S. E. and Loewy A. D. (1984) Substance P immunoreactivity released from rat spinal cord after kainic acid excitation of the ventral medulla oblongate: a correlation with increases in blood pressure. Brain Res. 291, 168-172.
47. Theodorsson-Norheim E., Hemsen A., Brodin E. and Lundberg J. M. (1987) Sample handling techniques when analyzing regulatory peptides. Life Sci. 41, 845-848.
48. Ward J. R. and Jones R. S. (1962) Studies on adjuvant-induced polyarthritis in rats. I. Adjuvant composition, route of injection, and removal of depot site. Arthr. Rheum. 5, 557-564.
49. Weihe E., Nohr D., Muller S., Buchler M., Friess H. and Zentel H. J. (1991) The tachykinin neuroimmune connection in inflammatory pain. Ann. NY Acad. Sci. 632, 283-295.
50. Yokoyama M. M. and Fujimoto K. (1990) Role of lymphocyte activation by Substance P in rheumatoid arthritis. Intl J. Tiss. Reac. XII, 1-9.